Your Health Plan:
Your Health Plan:
Not SelectedGIVLAARI (givosiran sodium) is a brand-name prescription drug for treatment of Porphobilinogen synthase deficiency. GIVLAARI is a small interfering rna / aminolevulinate synthase 1-directed rna interaction. It is available in the form of subcutaneous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $47400-55500.
Patient Assistance Prorgams and Coupons are found:
No other option is found for GIVLAARI